Ekarpen, a private equity firm backed by the government of the Basque Country, and Basque lender BBK have led a €9m funding round for Spanish biotechnology company Oncomatryx.
Company has raised €20m so far over two funding rounds
HV Holtzbrinck and Lakestar also participate in the round for the dental technology startup
IK VIII held a final close in November 2016 with €1.85bn and was 87% deployed as of December 2019
With the GP's support, Bomi intends to pursue an intensive buy-and-build strategy